Latest Information Update: 28 Nov 2006
At a glance
- Originator Roche
- Mechanism of Action Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Septic shock
Most Recent Events
- 04 Aug 1998 No-Development-Reported for Septic shock in USA (Unknown route)
- 14 May 1996 New profile
- 14 May 1996 Preclinical development for Septic shock in USA (Unknown route)